Diabetic Neuropathic Pain Relief, 6 Weeks Dosage Sublingual Water-soluble CBD/PEA

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2023
The purpose of the study is to evaluate whether the DIA/NPR-6 is a better pain reliever in patients with diabetic neuropathic pain of the feet compared to placebo.
Epistemonikos ID: 09592b95ce61a4fd681bc07a6bd5d829f506fc1c
First added on: Feb 19, 2024